Heartflow Expands GAMEFILM Registry to Former NBA and NHL Players
On February 12, Heartflow expanded its GAMEFILM Registry to include former NBA and NHL players, extending the study beyond retired NFL athletes to enhance cardiovascular risk insights across three major leagues. In late January, Wells Fargo initiated coverage with an overweight rating and $38 target, forecasting roughly 20% growth over three years driven by FFRCT and plaque volume analyses.
1. GAMEFILM Expansion Broadens Athlete Pool
On February 12, Heartflow announced the expansion of its GAMEFILM Registry from retired NFL athletes to include former NBA and NHL players. The broader cohort aims to deliver precise measurements of coronary plaque and flow reserve across three leagues, enriching the company’s dataset for AI-driven cardiovascular care.
2. Wells Fargo Coverage and Growth Projections
In late January, Wells Fargo initiated coverage of Heartflow with an overweight rating and a $38 price target. The firm highlighted Heartflow’s fractional flow reserve-computed tomography (FFRCT) and plaque volume analysis software as key growth drivers, forecasting approximately 20% revenue growth over the next three years.